Good Article, bad article, good article, bad article. It is ridiculous how these guys spin the same story and the stock moves. There is obvious obstacles but there are more opportunities. Buyout, Investment from Big Pharma are just a couple of the ways for ONVO to secure funding. Maybe they'll do a secondary at some point in the future. The stock will be over $10 trading on the Nasdaq. The guy who wrote the article is probably buying right now.